Zobrazeno 1 - 10
of 94
pro vyhledávání: '"M. Patricia Massicotte"'
Autor:
Anthonie W. A. Lensing, Christoph Male, Guy Young, Dagmar Kubitza, Gili Kenet, M. Patricia Massicotte, Anthony Chan, Angelo C. Molinari, Ulrike Nowak-Goettl, Ákos F. Pap, Ivet Adalbo, William T. Smith, Amy Mason, Kirstin Thelen, Scott D. Berkowitz, Mark Crowther, Stephan Schmidt, Victoria Price, Martin H. Prins, Paul Monagle
Publikováno v:
Thrombosis Journal, Vol 16, Iss 1, Pp 1-11 (2018)
Abstract Background Venous thromboembolism (VTE) is a relatively rare condition in childhood with treatment mainly based on extrapolation from studies in adults. Therefore, clinical trials of anticoagulation in children require novel approaches to de
Externí odkaz:
https://doaj.org/article/b6a58605a3f245d0935f0be64bd90cdc
Publikováno v:
Frontiers in Medicine, Vol 6 (2019)
Externí odkaz:
https://doaj.org/article/0064c1ae8c9f42a1a47007be7eebe464
Autor:
Julie K. Rehman, Gwen R. Rempel, Elina Williams, Leanne Meakins, Mary E. Bauman, M. Patricia Massicotte, Roberta Davis, Judy Dahl, Andrew S. Mackie
Publikováno v:
CJC Pediatric and Congenital Heart Disease.
Autor:
Philip C. Spinella, Marie E. Steiner, Jun Teruya, M. Patricia Massicotte, Ravi R. Thiagarajan, Christopher S. Almond, Ryan R. Davies, Lisa Baumann-Kreuziger, Jean M. Connors, Larry J. Dumont, Melania M. Bembea, Jerrold H. Levy, Keyvan Karkouti, Massimo Griselli, David Faraoni, Heidi J. Dalton
Publikováno v:
The Annals of Thoracic Surgery. 113:1026-1035
Research evaluating hemostatic agents for the treatment of clinically significant bleeding has been hampered by inconsistency and lack of standardized primary clinical trial outcomes. Clinical trials of hemostatic agents in both cardiac surgery and m
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mary E. Bauman, Kelsey R Balutis, Laurance Lequier, Lee-Ann Nelson, Lindsay M. Ryerson, Donald A. Granoski, M. Patricia Massicotte
Publikováno v:
Pediatric Critical Care Medicine. 21:975-985
OBJECTIVES Objective of this study was to determine if bivalirudin resulted in less circuit interventions than unfractionated heparin. A secondary objective was to examine associations between bivalirudin dose and partial thromboplastin time, interna
Autor:
M. Patricia Massicotte, Antonio Amodeo, J. Timothy Baldwin, Gianluigi Perri, Alessandra Rizza, Christopher S. Almond, Rachele Adorisio, Francesca Iodice, Sergio Filippelli, Roberta Iacobelli
Publikováno v:
The Journal of Heart and Lung Transplantation. 39:83-87
Autor:
M. Patricia Massicotte, Mary E. Bauman
Publikováno v:
Anesthesiology. 132:421-423
Autor:
Paola Saracco, Gili Kenet, Pascal Amedro, Christoph Male, Ildar Nurmeev, Cynthia Gauger, William T. Smith, M. Patricia Massicotte, Anthony K.C. Chan, Paul Monagle, Joyce Ching Mei Lam, Zeynep Karakas, Guy Young, Anthonie W. A. Lensing, Dagmar Kubitza, Scott D. Berkowitz, Damien Bonnet, Joseph S. Palumbo, Juan Chain, Takanari Ikeyama, Martin H. Prins, Akos F. Pap, Katharina Thom, Madhurima Majumder, Fanny Bajolle
Publikováno v:
Blood Advances
Blood Advances, The American Society of Hematology, 2020, 4 (19), pp.4632-4639. ⟨10.1182/bloodadvances.2020002637⟩
Blood Adv
Blood advances, 4(19), 4632-4639. The American Society of Hematology
Blood Advances, 2020, 4 (19), pp.4632-4639. ⟨10.1182/bloodadvances.2020002637⟩
Blood Advances, The American Society of Hematology, 2020, 4 (19), pp.4632-4639. ⟨10.1182/bloodadvances.2020002637⟩
Blood Adv
Blood advances, 4(19), 4632-4639. The American Society of Hematology
Blood Advances, 2020, 4 (19), pp.4632-4639. ⟨10.1182/bloodadvances.2020002637⟩
Anticoagulant treatment of pediatric central venous catheter–related venous thromboembolism (CVC-VTE) has not been specifically evaluated. In EINSTEIN-Jr, 500 children with any VTE received rivaroxaban or standard anticoagulants. A predefined analy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2048afb63040667c051dee86c6747007
https://hal.archives-ouvertes.fr/hal-02956411/document
https://hal.archives-ouvertes.fr/hal-02956411/document
Autor:
Ida Martinelli, Kirstin Thelen, Riten Kumar, Ildar Nurmeev, Anthony K.C. Chan, Susanne Holzhauer, Helene L. Hooimeijer, Victoria E. Price, Christoph Male, Marcela Torres, Guy Young, Kerry Hege, Scott D. Berkowitz, Philip Connor, Gili Kenet, Joseph S. Palumbo, M. Patricia Massicotte, William T. Smith, Stephan Schmidt, Stefan Willmann, Pascal Amedro, Dagmar Kubitza, Martin H. Prins, Paul Monagle, Fanny Bajolle, Amparo Santamaría, Jan Beyer-Westendorf, Anthonie W. A. Lensing
Publikováno v:
Journal of Thrombosis and Haemostasis, 18(7), 1672-1685. Wiley
Journal of Thrombosis and Haemostasis, 18(7), 1672-1685. Wiley-Blackwell Publishing Ltd
Journal of Thrombosis and Haemostasis
Journal of Thrombosis and Haemostasis, Wiley, 2020, 18 (7), pp.1672-1685. ⟨10.1111/jth.14813⟩
Journal of Thrombosis and Haemostasis, 18(7), 1672-1685. Wiley-Blackwell Publishing Ltd
Journal of Thrombosis and Haemostasis
Journal of Thrombosis and Haemostasis, Wiley, 2020, 18 (7), pp.1672-1685. ⟨10.1111/jth.14813⟩
Background: Recently, the randomized EINSTEIN-Jr study showed similar efficacy and safety for rivaroxaban and standard anticoagulation for treatment of pediatric venous thromboembolism (VTE). The rivaroxaban dosing strategy was established based on p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bb33de5b932faaa8296a766f914b6f7
https://cris.maastrichtuniversity.nl/en/publications/9350f763-2566-43cf-ad97-c3105f048487
https://cris.maastrichtuniversity.nl/en/publications/9350f763-2566-43cf-ad97-c3105f048487